The actual device was returned to the manufacturing facility for evaluation.Visual inspection found no anomalies in the appearance.There was no formation of clots inside the device.The actual sample, after having been rinsed, was subjected to another visual inspection.No break or plugging in the fiber was confirmed.The actual sample was built into a circuit with tubes, where bovine blood flowed directly.Blood was confirmed to run through the device.There was no difficulty with the filtrate pathway being filled with filtrate.Bovine blood was circulated in the circuit at the flow rate of 500ml/minute and tmp 400mmhg.During the circulation, the pressure loss was determined.The obtained values were confirmed to meet manufacturing specifications.Subsequently, the ultrafiltration performance was determined and verified to meet manufacturing specifications.A review of the device history record and product release decision control sheet of the involved product code/lot # combination was conducted with no relevant findings.A search of the complaint file found no other report with the involved product code/lot# combination.There is no evidence that this event was related to a device defect or malfunction.The inspection results verified the actual device was the normal product.While the exact cause of the reported event cannot be definitively determined based on the available information, it is likely that the volume of the blood sent into the actual sample was not sufficient.The device labeling does address the potential for such an event in the instruction for use (ifu) with statements such as the following: "the capiox hemoconcentrator is designed to operate at flow rates within the range of 100 to 500 ml/min during ultrafiltration.Do not use blood flow rates outside this range.Less than 100ml/min blood flow may cause blood coagulation in the device.Do not exceed 50% hematocrit at the blood outlet during ultrafiltration.Do not stop blood flow during extracorporeal circulation as it may cause clotting in the system.A blood flow at least 50l/min is recommended even if ultrafiltration is stopped by clamping the filtrate line." (b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
|